Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ascending Lucidity Descending Turbidity Decoction (Shengqing Jiangzhuo Decoction) is a Traditional Chinese Medicine (TCM) herbal formulation investigated for the treatment of malignant serous cavity effusions, including malignant ascites and pleural effusions. The decoction is based on TCM principles aimed at restoring fluid balance by "ascending the clear" (supporting healthy metabolic function) and "descending the turbid" (eliminating pathological fluid accumulation). In clinical trial settings, such as those conducted by the Shenzhen Hospital of Beijing University of Traditional Chinese Medicine, it is evaluated in combination with anti-angiogenic therapies like bevacizumab to enhance the control of fluid production and improve the quality of life in oncology patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ascending Lucidity Descending Turbidity Decoction.